These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9856270)

  • 1. [Physiopathology of langerhans-cell histiocytosis].
    Boralevi F; Taïeb A
    Ann Dermatol Venereol; 1998 Nov; 125(11):856-9. PubMed ID: 9856270
    [No Abstract]   [Full Text] [Related]  

  • 2. [Langerhans-cell histiocytosis. Recent data on diagnosis and physiopathology].
    Emile JF; Donadieu J; Thomas C; Brousse N
    Ann Pathol; 1995; 15(4):252-9. PubMed ID: 8519392
    [No Abstract]   [Full Text] [Related]  

  • 3. Histiocytosis X: a histological and histogenetic study.
    Nezelof C
    Perspect Pediatr Pathol; 1979; 5():153-78. PubMed ID: 317149
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients.
    Janik JE; Miller LL; Kopp WC; Taub DD; Dawson H; Stevens D; Kostboth P; Curti BD; Conlon KC; Dunn BK; Donegan SE; Ullrich R; Alvord WG; Gause BL; Longo DL
    Clin Immunol; 1999 Dec; 93(3):209-21. PubMed ID: 10600331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Langerhans cell histiocytosis(LCH)].
    Tsunematsu Y
    Ryoikibetsu Shokogun Shirizu; 2000; (32):590-4. PubMed ID: 11212814
    [No Abstract]   [Full Text] [Related]  

  • 6. Mixed Langerhans cell and interstitial/dermal dendritic cell subsets emanating from monocytes in Th2-mediated inflammatory conditions respond differently to proinflammatory stimuli.
    Bechetoille N; André V; Valladeau J; Perrier E; Dezutter-Dambuyant C
    J Leukoc Biol; 2006 Jul; 80(1):45-58. PubMed ID: 16614258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adult pulmonary Langerhans' cell histiocytosis].
    Soler P; Valeyre D
    Rev Med Interne; 2003 Apr; 24(4):230-6. PubMed ID: 12706779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cytokines in the pathogenesis of pulmonary Langerhans' cell histiocytosis.
    de Graaf JH; Mannes GP; Tamminga RY; Kamps WA; Timens W
    Adv Exp Med Biol; 1995; 378():535-7. PubMed ID: 8526136
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and immunohistochemical evaluation of the vulvar Langerhans cell histiocytosis.
    Bongiorno MR; Pistone G; de Giorgi V; Aricò M
    Dermatol Ther; 2008; 21 Suppl 3():S15-20. PubMed ID: 19076626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-4 inhibits granulocyte-macrophage colony-stimulating factor, interleukin-6, and tumor necrosis factor-alpha expression by human monocytes in response to polymethylmethacrylate particle challenge in vitro.
    Trindade MC; Nakashima Y; Lind M; Sun DH; Goodman SB; Maloney WJ; Schurman DJ; Smith RL
    J Orthop Res; 1999 Nov; 17(6):797-802. PubMed ID: 10632444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histiocytosis of the Langerhans cells. Etiopathogenesis and prognostic picture in the light of the most recent findings].
    Bucci E; Mignogna MD; de Donato C; Bucci P
    Minerva Stomatol; 1988 Apr; 37(4):305-14. PubMed ID: 3050433
    [No Abstract]   [Full Text] [Related]  

  • 12. Langerhans' cell histiocytosis pathobiology and pathogenesis.
    Favara BE
    Semin Oncol; 1991 Feb; 18(1):3-7. PubMed ID: 1704152
    [No Abstract]   [Full Text] [Related]  

  • 13. Maternal plasma cytokines in early- and mid-gestation of normal human pregnancy and their association with maternal factors.
    Curry AE; Vogel I; Skogstrand K; Drews C; Schendel DE; Flanders WD; Hougaard DM; Thorsen P
    J Reprod Immunol; 2008 Apr; 77(2):152-60. PubMed ID: 17692390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunoenzyme determination of human granulocyte-macrophage colony-stimulating factor using monoclonal antibodies].
    Lakhtina OE; Petrovskaia LE; Korobko VG; Nemeianov VA
    Bioorg Khim; 1999 Sep; 25(9):673-8. PubMed ID: 10624559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of large numbers of Langerhans' cells with intraepithelial migration ability in vitro.
    Hubert P; Bousarghin L; Greimers R; Franzen-Detrooz E; Boniver J; Delvenne P
    Exp Dermatol; 2005 Jun; 14(6):469-77. PubMed ID: 15885083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans cell histiocytosis: a pathologic combination of oncogenesis and immune dysregulation.
    Egeler RM; Annels NE; Hogendoorn PC
    Pediatr Blood Cancer; 2004 May; 42(5):401-3. PubMed ID: 15049009
    [No Abstract]   [Full Text] [Related]  

  • 17. [A benign course of histiocytosis X].
    Shikhveniev DA; Esedov EM; Dzhalilova LM
    Klin Med (Mosk); 2002; 80(7):52-4. PubMed ID: 12181819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lymphoma-like course in aggressive adult multisystem Langerhans cell histiocytosis].
    Veselý K
    Vnitr Lek; 2010 Nov; 56(11):1114-5. PubMed ID: 21250488
    [No Abstract]   [Full Text] [Related]  

  • 19. Release of cytokines by brain endothelial cells: A polarized response to lipopolysaccharide.
    Verma S; Nakaoke R; Dohgu S; Banks WA
    Brain Behav Immun; 2006 Sep; 20(5):449-55. PubMed ID: 16309883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Langerhans cell histiocytosis: an identity crisis.
    Favara BE
    Med Pediatr Oncol; 2001 Dec; 37(6):545. PubMed ID: 11745895
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.